Does zinc shorten the common cold?
Zinc may shorten an ongoing cold, especially longer ones, but it probably causes bad taste or nausea and does not clearly prevent colds.
Covers: This page covers the evidence from clinical trials and systematic reviews on oral zinc supplementation for treating or preventing the common cold in adults and children. It does not address zinc for other infections, topical zinc, or non-cold uses of zinc.
3 free full reads left this month. Join or upgrade

The short answer
Interpretation AI-prepared starting mapFor treating an ongoing cold, the most directly relevant synthesis concludes that zinc supplementation may reduce the duration of colds, while probably increasing non-serious adverse events such as bad taste and nausea (RR 1.34, 95% CI 1.15 to 1.55; 2084 participants, 16 studies; moderate-certainty evidence). The same review found little or no effect on preventing colds. A separate analysis of three trial datasets (zinc gluconate lozenges, zinc acetate lozenges, nasal carrageenan) found that treatment effects varied across the distribution of cold lengths: shorter colds showed smaller average effects than longer colds, so a single average difference in days may misrepresent the benefit. Formulation appears to matter: properly composed zinc lozenges have been reported to shorten colds, but this has not been reported for ordinary oral zinc tablets.123
- Evidence 19
- Interpretation 4
In brief
For an ongoing cold, zinc supplementation may shorten how long it lasts, but it probably also increases non-serious side effects such as bad taste and nausea.1
Evidence-backedThe benefit is not uniform: average effects are smaller for shorter colds and larger for longer ones, so a single average figure in days understates or overstates the effect depending on the cold.2
Evidence-backedFormulation matters: properly composed zinc lozenges have been reported to shorten colds, but not ordinary oral zinc tablets.3
Evidence-backedIntranasal zinc is not the same as oral zinc: nasal sprays have been linked to loss of smell and were the subject of a 2009 FDA warning to stop using them.3
Evidence-backed
At a glance
The picture in numbers
Live · updated just now
16 studies
The evidence behind it
5 sources- Trials1
- Other studies and data3
- Background1
When it was published
Newest from 2026
| Source | Kind | Year |
|---|---|---|
| Zinc for prevention and treatment of the common cold. | Other studies and data | 2024 |
| Estimating quantile treatment effect on the original scale of the outcome variable: a case study of common cold treatments. | Other studies and data | 2025 |
| Zinc and the common cold (Wikipedia) | Background | Unknown |
| The Role of Zinc in Pediatric Respiratory Infections: Evidence from Clinical Trials and Real-World Studies. | Trials | 2026 |
| Between Deficiency and Excess: The Dual Role of Selected Dietary Supplements in Immune Health. | Other studies and data | 2026 |
The community around it
- Contributions
- 0
- People
- 0
- Following
- 0
Nobody has added anything yet. Experience, evidence or a different view would show up here.
What it means for you
Which fits you?
Pick the situation closest to yours. Each answer says what it rests on.
If you have a cold that has already started and you are considering lozenges
zinc lozenges may shorten the cold, but expect a meaningful chance of bad taste or nausea, and note that the benefit is likely to be smaller for a short cold than a long one.123
Evidence-backedIf you are otherwise healthy and hoping to avoid catching colds
the evidence suggests zinc supplementation has little or no preventive effect in the general population.13
Evidence-backedIf you are a parent of a child with recurrent respiratory infections
preventive zinc, particularly as part of a multicomponent supplement used over a prolonged period, has been reported to reduce infection frequency and duration with a favourable safety profile, though the evidence for treating an acute infection is less consistent.4
Evidence-backedIf you have a confirmed or suspected zinc deficiency or are at high risk of one
supplementation is more likely to be worthwhile, since benefits appear concentrated in deficient or high-risk people, and indiscriminate supplementation carries its own risks.5
Evidence-backedIf you are considering a zinc nasal spray
do not treat this as equivalent to oral zinc: intranasal zinc has been associated with loss of the sense of smell and the FDA warned consumers to stop using it in 2009.3
Evidence-backedIf you want a single expected benefit in days before deciding
the evidence does not support one: effects vary with how long the cold would otherwise last, and the relative scale summarises the effect better than an average difference in days.2
Evidence-backedThe full story · 3 chapters
01
Zinc for treating a cold that has already started
AI summary:Zinc may shorten an ongoing cold, with the benefit concentrated in longer colds and seen with lozenges rather than plain tablets, alongside likely bad taste or nausea.
Evidence-backed: The most directly relevant synthesis reports that zinc supplementation may reduce the duration of ongoing colds. It also reports a probable increase in non-serious adverse events during treatment (RR 1.34, 95% CI 1.15 to 1.55; 2084 participants across 16 studies; moderate-certainty evidence). No treatment study in that review provided information on serious adverse events, and none clearly reported on adverse events that could be complications of the cold.1
Evidence-backed: How the benefit is distributed matters for interpretation. An analysis of three trial datasets found substantial variation in treatment effect across the range of cold durations: shorter colds showed smaller average effects than longer colds, which means a single average difference in days can be misleading. On the relative scale, the effect was summarised better than as a mean difference in days.2
Evidence-backed: Formulation is a recurring theme. Properly composed zinc lozenges (frequently zinc acetate or zinc gluconate) have been reported to shorten colds, but this effect has not been reported for ordinary oral zinc tablets. Reported adverse effects of oral zinc include bad taste and nausea.3
Interpretation: Taken together, the case for treating an existing cold rests on a probable shortening of duration, concentrated in longer colds, with lozenge formulations rather than plain tablets, and with a real chance of unpleasant but non-serious side effects. The size of the benefit for any individual cold is not well captured by a single average figure.123
When you have a common cold, do you take zinc supplements to try to shorten it?
Your individual response is private. Only totals are shown.
02
Zinc for preventing colds
AI summary:Prevention is not supported for the general population, but may help children with recurrent infections and people who are zinc-deficient or at high risk.
Evidence-backed: The main synthesis found that zinc supplementation may have little or no effect on preventing colds. A general reference source likewise states there is no evidence that zinc supplementation prevents colds in the general population.13
Evidence-backed: A pediatric review reaches a more positive conclusion for a narrower group: it reports consistent support for a preventive role of zinc in reducing the incidence and burden of respiratory infections, particularly in children with recurrent disease and in zinc-deficient populations. It notes that zinc-containing multicomponent supplements reduced infection frequency and duration with a favourable safety profile, and that effectiveness appeared to depend on treatment duration, baseline nutritional status and formulation.4
Evidence-backed: A further review argues that while zinc deficiency increases susceptibility to infection, supplementation mainly benefits people who are deficient or at high risk, and warns against indiscriminate supplementation. This suggests the apparent disagreement about prevention may partly reflect who was studied and their baseline zinc status.5
Interpretation: The most defensible reading is that prevention is not supported for the general adult population, but may hold for children with recurrent respiratory infections and for people with deficient or high-risk zinc status, especially with prolonged use and multicomponent formulations. The material does not establish a threshold of zinc status at which prevention begins to work.145
03
Why zinc might work, and what to watch for
AI summary:Zinc may work by suppressing nasal inflammation and rhinoviral activity; oral side effects are mostly non-serious, while intranasal zinc carries a separate warning about loss of smell.
Evidence-backed: The proposed mechanism is suppression of nasal inflammation and direct inhibition of rhinoviral receptor binding and rhinoviral replication in the nasal mucosa; the human rhinovirus is the predominant cause of the common cold.3
Evidence-backed: For oral supplements, reported adverse effects include bad taste and nausea, and the main synthesis quantifies a probable increase in non-serious adverse events during treatment. Intranasal zinc is a separate case: zinc-containing nasal sprays have been associated with loss of the sense of smell, and in June 2009 the US Food and Drug Administration warned consumers to stop using intranasal zinc.13
Interpretation: The safety picture for oral zinc is therefore mostly about unpleasant but non-serious effects, with serious adverse events and cold-complication events not clearly reported in treatment trials. The intranasal warning is a distinct and more serious concern that does not apply to lozenges or tablets.13
Ask this Sylo
Still wondering about something?
Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.
Behind this page
Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.
Discussion
Sources
Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.
- 1Zinc for prevention and treatment of the common cold.The Cochrane database of systematic reviews (Nault et al.)Published May 9, 2024Checked Oct 4, 2026
“There is probably an increase in the risk of non-serious adverse events when zinc is used for cold treatment (RR 1.34, 95% CI 1.15 to 1.55; I2 = 44%; 2084 participants, 16 studies; moderate-certainty evidence); no treatment study provided information on serious adverse events. No study provided clear information about adverse events considered to be potential complications of the common cold.Authors' conclusionsThe findings suggest that zinc supplementation may have little or no effect on the prevention of colds but may reduce the duration of ongoing colds, with an increase in non-serious adverse events. Overall, there was wide variation in interventions (including concomitant therapy) and outcomes across the studies, as well as incomplete reporting of several domains, which should be considered when making conclusions about the efficacy of zinc for the common cold.”
- 2Estimating quantile treatment effect on the original scale of the outcome variable: a case study of common cold treatments.Trials (Hemilä & Pirinen)Published Nov 24, 2025Checked Oct 4, 2026
“We further derive informative bounds for the average treatment effect at the upper and lower tails of the distribution. The method was applied to 3 datasets on the treatment of the common cold: zinc gluconate lozenges, zinc acetate lozenges, and nasal carrageenan.ResultsAcross all 3 datasets, BQTE revealed substantial heterogeneity in treatment effects on the units of measurement scale (days). Specifically, shorter colds showed smaller average effects than longer colds, indicating that the assumption of a constant mean difference across the distribution may be inappropriate. In all cases, the relative scale provided a better summary of the BQTE distribution than the mean difference.ConclusionsThe BQTE method enhances the interpretability of QTEs by presenting results on the outcome's original scale. It provides a nuanced understanding of how the average treatment effect varies across the distribution. BQTE is particularly suited for analyzing continuous clinical outcomes such as illness duration or hospital stay and offers a valuable complement to the standard effect size measures in individual-patient data meta-analysis and clinical trial reporting.”
- 3Zinc and the common cold (Wikipedia)WikipediaPublished Oct 1, 2026Checked Oct 4, 2026
“Zinc supplements (frequently zinc acetate or zinc gluconate lozenges) are a group of dietary supplements that are commonly used in an attempt to treat the common cold. There is no evidence that zinc supplementation prevents colds in the general population. There is evidence that properly composed zinc lozenges can shorten the duration of colds, but this effect has not been reported for ordinary oral zinc tablets. Adverse effects with zinc supplements by mouth include bad taste and nausea. The intranasal use of zinc-containing nasal sprays has been associated with the loss of the sense of smell; consequently, in June 2009, the United States Food and Drug Administration (USFDA) warned consumers to stop using intranasal zinc. The human rhinovirus – the most common viral pathogen in humans – is the predominant cause of the common cold. The hypothesized mechanism of action by which zinc reduces the severity and/or duration of cold symptoms is the suppression of nasal inflammation and the direct inhibition of rhinoviral receptor binding and rhinoviral replication in the nasal mucosa.”
- 4The Role of Zinc in Pediatric Respiratory Infections: Evidence from Clinical Trials and Real-World Studies.Nutrients (Dinardo et al.)Published Feb 7, 2026Checked Oct 4, 2026
“Evidence consistently supports a preventive role of zinc supplementation in reducing the incidence and burden of respiratory infections, particularly in children with recurrent disease and in zinc-deficient populations. Zinc-containing multicomponent supplements demonstrated significant reductions in infection frequency and duration, alongside improved patient and parent-reported outcomes, with a favorable safety profile. In contrast, data on zinc as an adjunctive treatment during acute infections, especially severe pneumonia, are less consistent, with limited impact on major clinical outcomes. The effectiveness of zinc appears to be influenced by treatment duration, baseline nutritional status, and formulation. In conclusion, zinc may represent a valuable component of preventive immune-nutritional strategies for pediatric respiratory infections, especially when administered as part of multicomponent formulations and over prolonged periods. While its role in acute disease management remains uncertain, optimizing zinc status may contribute to reducing infection recurrence and overall disease burden.”
- 5Between Deficiency and Excess: The Dual Role of Selected Dietary Supplements in Immune Health.Cureus (Skrzypska et al.)Published Feb 21, 2026Checked Oct 4, 2026
“While zinc deficiency increases infection susceptibility, supplementation benefits primarily those with deficient or high-risk status. Selenium, a key component of selenoproteins like glutathione peroxidase, supports antioxidant defense and modulates cell-mediated immunity. Evidence indicates that selenium may enhance immune function in deficient individuals; however, excessive intake carries a narrow therapeutic window and potential toxicity. Vitamin C contributes to defense by maintaining epithelial barrier integrity, supporting leukocyte chemotaxis, and modulating oxidative stress. While routine high-dose supplementation offers limited benefits in healthy individuals, adequate intake remains crucial for those with low dietary consumption. This review highlights the risks associated with indiscriminate supplementation. While zinc, selenium, and vitamin C are indispensable for optimal immunity, their use should be individualized and targeted toward correcting confirmed deficiencies. A personalized, evidence-based approach remains essential for supporting immune health while minimizing potential risks.”
How it changed
Published 1 time since Oct 4, 2026.
- Version 2Oct 4, 2026Live now
AI-prepared Starting Map from live research.
- First published version.
Help improve it
The brief is open about what's uncertain. These are the specific gaps that new material would fill.
Open questions
Which specific lozenge formulations and doses produce a reliable shortening of colds, and why has this not been shown for ordinary oral zinc tablets?
No answers yet
Does baseline zinc status identify who will benefit, and is there a threshold below which supplementation helps and above which it does not?
No answers yet
Why are average effects larger for longer colds, and does that mean zinc should be targeted at people whose colds tend to last longer?
No answers yet
Can the preventive benefit reported in children with recurrent infections be reproduced in general-population children, and does it depend on multicomponent supplements or prolonged use?
No answers yet
What is the risk of serious adverse events and of cold complications during zinc treatment, given that treatment trials have not clearly reported them?
No answers yet
Around this topic
Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.